Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02168075 : Mannitol Brain Relaxation Effect
PhaseN/A
AgesMin: 20 Years Max: 80 Years
Eligibility
Inclusion Criteria:

- Patients who underwent craniotomy for supratentorial brain tumor under general
anesthesia

Exclusion Criteria:

- Patient who does not agree to the study

- Patients with or American Society of Anesthesiologists (ASA) physical status class IV
or more

- Patients with glasgow coma scale (GCS) under 13 points

- Patients who have hyponatremia or hypernatremia (Na<130 or >150mEq/L)

- Patients who have congestive heart failure or moderately decreased renal function
(GFR <60ml/min/1.73m2)

- Patients with extraventricular drainage such as external ventricular drain (EVD) or
ventriculoperitoneal (VP) shunt

- Patients who already under mannitolization
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02168075      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740